Yu Yu Li from Richmond, TX, age 44

Lawyers & Attorneys

Yu Li - Lawyer

view source

Address:

(391)1527651 (Office)

Licenses:

Wisconsin - Good Standing 2004

Education:

University of Wisconsin Law School
Graduated - 2004

Languages:

English
Mandarin

Yu Li - Lawyer

view source

Licenses:

New York - Currently registered 2013

Education:

Indiana University School of Law

Medicine Doctors

Yu J. Li

view source

Description:

Dr. Li graduated from the China Med Univ, Shenyang City, Liaoning, China in 1985. He works in Davenport, IA and 1 other location and specializes in Anatomic Pathology & Clinical Pathology. Dr. Li is affiliated with Trinity Medical Center Moline, Unitypoint Health Trinity, UnityPoint Health Trinity Bettendorf and Unitypoint Health Trinity Regional Medical Center.

Name / Title

Company / Classification

Phones & Addresses

Yu Li
Director, President

FVK3 LLC
Nonclassifiable Establishments

3107 Auburn Path, Sugar Land, TX 77479
3110 Auburn Path, Sugar Land, TX 77479

Yu Li
Principal

Y & P Global Company
Nonclassifiable Establishments

855 Mcallister St, San Francisco, CA 94102

Yu Hui Li
Treasurer

HOCKEY MINISTRIES INTERNATIONAL

Yu Li
Managing

YUNFU LLC

3110 Auburn Path, Sugar Land, TX 77479

Yu Li
Manager, Director

LEOLE INTERNATIONAL LLC

14905 SW Fwy STE 232, Sugar Land, TX 77478
10555 Turtlewood No 1007, Houston, TX 77072

Yu Tao Li

Noved Ventures, LLC
Real Estate Investment · Nonclassifiable Establishments · Nonresidential Building Operator

1041 Irving St, San Francisco, CA 94122

Yu Li

Ikids Education Center, LLC
Individual/Family Services

35500 Dumbarton Ct, Newark, CA 94560

Yu Hong Li

SOM EXPRESS, INC

Us Patents

Uses Of Lp-Pla2 In Combination To Assess Coronary Risk
view source
US Patent:

20070077614, Apr 5, 2007
Filed:

Apr 1, 2004
Appl. No.:

10/552084
Inventors:

Robert Wolfert - Palo Alto CA, US
Yu Maguire - San Francisco CA, US
Yu Li - Fremont CA, US
Mark Sarno - Encinitas CA, US
International Classification:

C12Q 1/34
US Classification:

435018000
Abstract:

This invention relates to a method for assessing risk of Coronary Vascular Disease (CVD). Specifically, it relates to utilizing risk assessment from both Lipoprotein Associated Phospholipase A2 (Lp-PLA2) and C-reactive protein (CRP) in combination. In addition the invention relates to a method for assessing risk of Coronary Vascular Disease (CVD) in a patient with low to normal Low Density Lipoprotein Cholesterol (LDL) levels utilizing both LDL and Lipoprotein Associated Phospholipase A2 (Lp-PLA2). Moreover, the invention relates to the use of risk associated with Lp-PLA2, CRP and LDL in combination and specific ranges thereof to predict Coronary Vascular Disease.

Uses Of Lp-Pla2 In Combination To Assess Coronary Risk
view source
US Patent:

20110070223, Mar 24, 2011
Filed:

Nov 24, 2010
Appl. No.:

12/953687
Inventors:

Robert L. Wolfert - Palo Alto CA, US
Yu Ping Maguire - Kensington CA, US
Yu Ping Li - Fremont CA, US
Mark Joseph Sarno - Encinitas CA, US
Assignee:

diaDexus, Inc. - South San Francisco CA
International Classification:

A61K 39/395
A61P 3/00
C12Q 1/60
US Classification:

4241301, 435 11
Abstract:

This invention relates to a method for assessing risk of Coronary Vascular Disease (CVD). Specifically, it relates to utilizing risk assessment from both Lipoprotein Associated Phospholipase A2 (Lp-PLA2) and C-reactive protein (CRP) in combination. In addition the invention relates to a method for assessing risk of Coronary Vascular Disease (CVD) in a patient with low to normal Low Density Lipoprotein Cholesterol (LDL) levels utilizing both LDL and Lipoprotein Associated Phospholipase A2 (Lp-PLA2). Moreover, the invention relates to the use of risk associated with Lp-PLA2, CRP and LDL in combination and specific ranges thereof to predict Coronary Vascular Disease.

Electrophoretic Dispersion
view source
US Patent:

20120112131, May 10, 2012
Filed:

Nov 2, 2011
Appl. No.:

13/287704
Inventors:

Yu Li - Fremont CA, US
Hui Du - Milpitas CA, US
Yayong Liu - Fremont CA, US
Haiyan Gu - Fremont CA, US
HongMei Zang - Fremont CA, US
International Classification:

H01B 1/12
C08F 292/00
US Classification:

252500, 526172
Abstract:

The present invention is directed to an electrophoretic dispersion comprising pigment particles dispersed in a solvent or solvent mixture, wherein said pigment particles comprises at least one polymer chain comprising a terminal thiocarbonylthio group, attached to the particle surface. The invention also relates to pigment particles suitable for use in an electrophoretic dispersion and methods for their preparation through a RAFT polymerization technique.

Additive For Improving Optical Performance Of An Electrophoretic Display
view source
US Patent:

20130077155, Mar 28, 2013
Filed:

Sep 23, 2011
Appl. No.:

13/243751
Inventors:

Ming Wang - Union City CA, US
Yu Li - Fremont CA, US
Hui Du - Milpitas CA, US
Xiaojia Wang - Fremont CA, US
Haiyan Gu - Fremont CA, US
Roman Ivanov - Milpitas CA, US
Robert Sprague - Saratoga CA, US
International Classification:

G02F 1/00
H01B 1/12
US Classification:

359321, 252500
Abstract:

The present invention is directed to an electrophoretic fluid comprising uncharged or lightly charged neutral buoyancy particles. The resulting fluid can improve not only image stability but also contrast ratio of a display device, without significantly affecting the switching speed. The present invention is also directed to an electrophoretic display comprising display cells filled with the electrophoretic fluid.

Electrophoretic Dispersion
view source
US Patent:

20130193385, Aug 1, 2013
Filed:

Jan 27, 2012
Appl. No.:

13/360482
Inventors:

Yu Li - Fremont CA, US
Hui Du - Milpitas CA, US
Haiyan Gu - Fremont CA, US
International Classification:

H01B 1/12
H01B 1/20
H01B 1/00
US Classification:

25251933, 252500
Abstract:

The present invention is directed to an electrophoretic dispersion comprising charged pigment particles dispersed in a solvent or solvent mixture, wherein the pigment particles have an average aggregation size more than 2 times their primary size. The electrophoretic dispersion of the present invention is capable of improving image bistability through adjusting the aggregation size of the charged pigment particles.

Anti-Cancer Oncolytic Virus Combination Therapies And Elite Responder Selection Platforms
view source
US Patent:

20220331385, Oct 20, 2022
Filed:

Apr 21, 2022
Appl. No.:

17/660051
Inventors:

Minjie HU - Foster City CA, US
Yu Li - Johns Creek GA, US
Xiaoling Liu - Pearland TX, US
Rebecca Hu - Foster City CA, US
Assignee:

Suzhou Prajna Biotech Co., Ltd. - Sip
International Classification:

A61K 35/768
A61K 39/39
A61K 35/745
A61P 35/00
A61K 35/741
A61K 45/06
C12N 7/00
Abstract:

Therapeutic methods for administering gut microbiota and oncolytic viruses to a subject are provided. The gut microbiota serve to pre-condition, the subject's immune system to antitumor responses and augments anticancer activity of the oncolytic vims. Combinations of the gut, microbiota and viruses and uses thereof for treating and preventing cancer are provided. The present disclosure also provides methods for building elite responder selection platforms through hierarchical clustering analysis of genomic profiles for human gut microbiome.

Anisotropic Conductive Dielectric Layer For Electrophoretic Display
view source
US Patent:

20200201133, Jun 25, 2020
Filed:

Feb 28, 2020
Appl. No.:

16/804336
Inventors:

- Fremont CA, US
Yu LI - Fremont CA, US
Peter B. LAXTON - Marshfield MA, US
Lei LIU - Fremont CA, US
Hui DU - Milpitas CA, US
HongMei ZANG - Fremont CA, US
International Classification:

G02F 1/167
Abstract:

The present invention is directed to an electrophoretic display device comprising microcells filled with an electrophoretic fluid and a dielectric layer, which comprises a first type of magnetic filler material, a second type of nonmagnetic filler material, and a polymeric material. The first and second types of filler material physically interact with each other and they are fixed and aligned in the dielectric adhesive layer in a direction perpendicular to a plane of the dielectric layer. The dielectric layer exhibits anisotropic conductivity having higher conductivity in the z direction compared to the other two orthogonal directions.

Color Display Device
view source
US Patent:

20190333436, Oct 31, 2019
Filed:

May 15, 2019
Appl. No.:

16/412684
Inventors:

- Fremont CA, US
Yu LI - Fremont CA, US
Hui DU - Milpitas CA, US
Xiaojia ZHANG - Fremont CA, US
Craig LIN - Fremont CA, US
International Classification:

G09G 3/20
G02F 1/167
G02F 1/133
G09G 3/34
G02B 26/00
G02B 26/02
Abstract:

The present invention provides a solution for a highlight or multicolor display device, in which each display cell can display high quality color states. More specifically, an electrophoretic fluid is provided which comprises three types of pigment particles, having different levels of size, threshold voltage or charge intensity.